Package 69680-158-93

{"route": ["ORAL"], "spl_id": "c7d45984-a653-4be6-9b1c-986a553e4e42", "openfda": {"upc": ["0369680158921", "0369680157900", "0369680157924", "0369680158303", "0369680158938", "0369680157306", "0369680157931"], "unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["f53704b2-3d3c-47e8-9fd6-a0f5240c0593"], "manufacturer_name": ["Vitruvias Therapeutics"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-158-30)", "package_ndc": "69680-158-30", "marketing_start_date": "20230410"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-158-90)", "package_ndc": "69680-158-90", "marketing_start_date": "20230410"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-158-92)", "package_ndc": "69680-158-92", "marketing_start_date": "20230410"}, {"sample": false, "description": "1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (69680-158-93)", "package_ndc": "69680-158-93", "marketing_start_date": "20230410"}], "brand_name": "Bupropion hydrochloride (XL)", "product_id": "69680-158_c7d45984-a653-4be6-9b1c-986a553e4e42", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "69680-158", "generic_name": "Bupropion hydrochloride", "labeler_name": "Vitruvias Therapeutics", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion hydrochloride (XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA208652", "marketing_category": "ANDA", "marketing_start_date": "20230410", "listing_expiration_date": "20271231"}